Cannabigerol (CBG) A Cannabinoid That Should Not Be Overlooked

By: med_admin Published: November 8, 2016

There are many active and inactive compounds (well over 100) in the cannabis plant, which hold great promise for successfully treating a plethora of medical complaints. Understanding what these compounds are can help assure their use in helping you or a loved one suffering from pain or illness.

When it comes to cannabinoids, there’s one of which you may not have heard. This article will focus on that lesser known cannabinoid, Cannabigerol (CBG). Although tetrahydrocannabinol (THC) and cannabidiol (CBD) are probably the most well-known cannabinoids, CBG is receiving increased national and international attention in the medical marijuana world, and for good reason.

In addition to the news that CBG has proven effective in providing relief from epileptic seizures in children without producing the psychotropic effect of THC, there are many other medical and therapeutic benefits of this cannabinoid.

CBG is known for:

  • anti-bacterial properties
  • ability to promote bone growth
  • inhibiting tumor or cancerous cell growth
  • anti-inflammatory, analgesic and anti-fungal

CBG is also being looked at as a possible treatment for many disorders, including:

  • cancer
  • glaucoma
  • inflammatory bowel disease
  • different types of pain
  • neurodegenerative diseases such as Huntington’s, Parkinson’s, and Multiple Sclerosis

The possibilities for the medical application of CBG seem endless. Human clinical trials are currently underway to determine the effectiveness of CBG on conditions such as psoriasis and eczema, and in late September, 2016 the release of the first ever high CBG oil was announced by Whistler Medical Marijuana Corporation. Some states are even passing “CBD-only” medical marijuana legislation.

Although several studies have shown that many are effective for treating multiple medical conditions on their own, all cannabinoids actually work best together. This is known as the “entourage effect”, a term first used by Israeli scientists Shimon Ben-Shabat and Raphael Mechoulam in 1998. The basic idea, which is somewhat controversial in the pharmacology community, is that cannabinoids within the cannabis plant possess synergy, and that, in certain cases, whole plant extractions work better than individual cannabinoids.

Whether you are seeking individual cannabinoid treatment, whole plant extractions, or are not sure what type of treatment will work best for you, if you have any symptoms that fit the legal MMJ requirements in Colorado, contact Medical Alternatives Clinics for your consultation today.

Posted in Medical Alternatives MMJ Blog | Tagged | No Comments

Comments are closed.